Toggle Offcanvas
...
 
Ritonavir Tenders

Ritonavir Tenders

View Ritonavir tenders, RFPs and contracts. Bid on readily available Ritonavir tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Ritonavir tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Ritonavir.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Ritonavir market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Ritonavir tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

137 Live Notices for Ritonavir Tenders

Showing 1 to 20

Securing Medicine Items For The Security Forces Hospital In Mecca
country Saudi Arabia
posting date03 Feb 2025
deadline02 Oct 2025
Hiv Medications
country Romania
posting date31 Jan 2025
deadline11 Mar 2025
Lopinavir/Ritonavir Combination Supply (Doe)
country Spain
posting date27 Jan 2025
deadline11 Feb 2025
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ritonavir (J05Ae03) As Part Of A So-Called Open-House Model.
country Germany
posting date24 Jan 2025
deadline31 Dec 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ritonavir (J05Ae03) As Part Of A So-Called Open-House Model.
country Germany
posting date14 Jan 2025
deadline31 Dec 2026
Antiretrovirals 2025
country Uruguay
posting date31 Dec 2024
deadline12 Feb 2025
Open House Drug Rebate Agreements Lopinavir And Ritonavir, Atc J05Ar10
country Germany
posting date17 Sep 2024
deadline05 Sep 2026
Open House Drug Rebate Agreements Lopinavir And Ritonavir, Atc J05Ar10
country Germany
posting date17 Sep 2024
deadline05 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026

Share Share this page